Credit Agricole’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $44.2K | Hold |
1,300
| – | – | ﹤0.01% | 1064 |
|
2024
Q4 | $51.2K | Hold |
1,300
| – | – | ﹤0.01% | 1082 |
|
2024
Q3 | $61.1K | Hold |
1,300
| – | – | ﹤0.01% | 1045 |
|
2024
Q2 | $70.2K | Hold |
1,300
| – | – | ﹤0.01% | 903 |
|
2024
Q1 | $73K | Hold |
1,300
| – | – | ﹤0.01% | 687 |
|
2023
Q4 | $81.4K | Hold |
1,300
| – | – | ﹤0.01% | 667 |
|
2023
Q3 | $59K | Hold |
1,300
| – | – | ﹤0.01% | 688 |
|
2023
Q2 | $73K | Hold |
1,300
| – | – | ﹤0.01% | 416 |
|
2023
Q1 | $58.8K | Hold |
1,300
| – | – | ﹤0.01% | 417 |
|
2022
Q4 | $52.8K | Hold |
1,300
| – | – | ﹤0.01% | 431 |
|
2022
Q3 | $85K | Hold |
1,300
| – | – | ﹤0.01% | 388 |
|
2022
Q2 | $79K | Sell |
1,300
-100
| -7% | -$6.08K | ﹤0.01% | 393 |
|
2022
Q1 | $88K | Sell |
1,400
-5,200
| -79% | -$327K | ﹤0.01% | 411 |
|
2021
Q4 | $500K | Buy |
6,600
+5,000
| +313% | +$379K | 0.01% | 274 |
|
2021
Q3 | $179K | Buy |
+1,600
| New | +$179K | ﹤0.01% | 325 |
|